Article

Strengthening National Reference Laboratories in the Republic of Congo: An Investment Imperative for Tuberculosis Surveillance

2025-11-10

Abstract excerpt

National Tuberculosis Reference Laboratories (NTRLs) are central to tuberculosis (TB) control programs. Between 2018 and 2025, the Republic of Congo, a country of 6 million inhabitants, achieved a transformative strengthening of its TB diagnostic system, coordinated by the NTRL. Strategic investments, supported mainly by international partners, enabled a substantial decentralization of services, expanding the diag...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f7866f9-0238-501d-9ed6-8cd816848373
DOI: 10.20944/preprints202511.0681.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Strengthening National Reference Laboratories in the Republic of Congo: An Investment Imperative for Tuberculosis SurveillanceDOI 10.20944/preprints202511.0681.v1Read

Considering best practice standards for routine whole-genome sequencing for TB care and controlSemantic proximity Read

Improving testing capacity for COVID-19: Experiences and lessons from Senegal, Uganda, Nigeria and the Democratic Republic of CongoSemantic proximity Read

Consolidation of a Genomic Epidemiological Surveillance Network for Tuberculosis (REVIGET) in Northern and Northeastern Brazil: A Study ProtocolSemantic proximity Read

Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients Semantic proximity Read

The African measles and rubella laboratory network: 21 years of functioning in West Africa.Semantic proximity Read

Evaluation of GeneXpert® in Brazil Through a Historical and Epidemiological ApproachSemantic proximity Read

Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysisSemantic proximity Read

Lessons Learnt from a Five-Year Experience of the Groupe de Recherche Action en Santé (GRAS) Clinical Laboratory, Burkina Faso, in Participating to an External Proficiency Testing (EPT) ProgrammeSemantic proximity Read

Integrated Use of the GeneXpert Platform for TB, HIV and EVD testing in LiberiaSemantic proximity Read

Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.Semantic proximity Read

Multi drug resistant tuberculosis in Mosango, a rural area in the Democratic Republic of Congo.Semantic proximity Read

Evaluating the Early Adaptation of a Multi-Component Active Case Finding Strategy for Drug-Resistant Tuberculosis in Aden, Yemen: Implementation Science StudySemantic proximity Read